Last edition
News about "Alberto Papi"
EU Approves Trixeo for Asthma Maintenance Treatment
Trixeo is approved in the EU for asthma maintenance treatment, becoming the first and only triple-combination therapy for patients aged 12 years and older.
Alberto Papi | 24/09/2026 | By News Bureau
CHMP Recommends AstraZeneca's Trixeo for EU Approval in Asthma
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended EU approval of AstraZeneca's Trixeo for asthma maintenance, backed by positive phase 3 KALOS and LOGOS trial results.
Alberto Papi | 25/07/2026 | By News Bureau | 239
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy